137 related articles for article (PubMed ID: 22650303)
1. Proliferative human cell sources applied as biocomponent in bioartificial livers: a review.
Nibourg GA; Chamuleau RA; van Gulik TM; Hoekstra R
Expert Opin Biol Ther; 2012 Jul; 12(7):905-21. PubMed ID: 22650303
[TBL] [Abstract][Full Text] [Related]
2. Bioartificial livers in vitro and in vivo: tailoring biocomponents to the expanding variety of applications.
van Wenum M; Chamuleau RA; van Gulik TM; Siliakus A; Seppen J; Hoekstra R
Expert Opin Biol Ther; 2014 Dec; 14(12):1745-60. PubMed ID: 25366164
[TBL] [Abstract][Full Text] [Related]
3. Increased hepatic functionality of the human hepatoma cell line HepaRG cultured in the AMC bioreactor.
Nibourg GA; Hoekstra R; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Chamuleau RA
Int J Biochem Cell Biol; 2013 Aug; 45(8):1860-8. PubMed ID: 23770120
[TBL] [Abstract][Full Text] [Related]
4. Selecting Cells for Bioartificial Liver Devices and the Importance of a 3D Culture Environment: A Functional Comparison between the HepaRG and C3A Cell Lines.
van Wenum M; Adam AA; Hakvoort TB; Hendriks EJ; Shevchenko V; van Gulik TM; Chamuleau RA; Hoekstra R
Int J Biol Sci; 2016; 12(8):964-78. PubMed ID: 27489500
[TBL] [Abstract][Full Text] [Related]
5. Liver support therapy: an overview of the AMC-bioartificial liver research.
van de Kerkhove MP; Poyck PP; Deurholt T; Hoekstra R; Chamuleau RA; van Gulik TM
Dig Surg; 2005; 22(4):254-64. PubMed ID: 16174982
[TBL] [Abstract][Full Text] [Related]
6. HepaRG-Progenitor Cell Derived Hepatocytes Cultured in Bioartificial Livers Are Protected from Healthy- and Acute Liver Failure-Plasma Induced Toxicity.
van Wenum M; Treskes P; Adam AAA; van der Mark VA; Jongejan A; Moerland PD; van Gulik TM; Oude Elferink RPJ; Chamuleau RAFM; Hoekstra R
Cell Physiol Biochem; 2018; 48(5):2189-2204. PubMed ID: 30110678
[TBL] [Abstract][Full Text] [Related]
7. Use of a rotary bioartificial liver in the differentiation of human liver stem cells.
Fonsato V; Herrera MB; Buttiglieri S; Gatti S; Camussi G; Tetta C
Tissue Eng Part C Methods; 2010 Feb; 16(1):123-32. PubMed ID: 19397473
[TBL] [Abstract][Full Text] [Related]
8. Perfusion flow rate substantially contributes to the performance of the HepaRG-AMC-bioartificial liver.
Nibourg GA; Boer JD; van der Hoeven TV; Ackermans MT; van Gulik TM; Chamuleau RA; Hoekstra R
Biotechnol Bioeng; 2012 Dec; 109(12):3182-8. PubMed ID: 22729831
[TBL] [Abstract][Full Text] [Related]
9. Liver progenitor cell line HepaRG differentiated in a bioartificial liver effectively supplies liver support to rats with acute liver failure.
Nibourg GA; Chamuleau RA; van der Hoeven TV; Maas MA; Ruiter AF; Lamers WH; Oude Elferink RP; van Gulik TM; Hoekstra R
PLoS One; 2012; 7(6):e38778. PubMed ID: 22719943
[TBL] [Abstract][Full Text] [Related]
10. [Liver and artificial liver].
Chamuleau RA
Ned Tijdschr Geneeskd; 1998 Jun; 142(23):1300-5. PubMed ID: 9752034
[TBL] [Abstract][Full Text] [Related]
11. Progress in bioreactors of bioartificial livers.
Yu CB; Pan XP; Li LJ
Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):134-40. PubMed ID: 19357025
[TBL] [Abstract][Full Text] [Related]
12. Hybrid bioartificial liver: establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use.
Kobayashi N; Okitsu T; Nakaji S; Tanaka N
J Artif Organs; 2003; 6(4):236-44. PubMed ID: 14691665
[TBL] [Abstract][Full Text] [Related]
13. Which are the right cells to be used in a bioartificial liver?
Chamuleau RA; Deurholt T; Hoekstra R
Metab Brain Dis; 2005 Dec; 20(4):327-35. PubMed ID: 16382343
[TBL] [Abstract][Full Text] [Related]
14. Functional and morphological comparison of three primary liver cell types cultured in the AMC bioartificial liver.
Poyck PP; Hoekstra R; van Wijk AC; Attanasio C; Calise F; Chamuleau RA; van Gulik TM
Liver Transpl; 2007 Apr; 13(4):589-98. PubMed ID: 17394165
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute-liver-failure-plasma exposure on hepatic functionality of HepaRG-AMC-bioartificial liver.
Nibourg GA; Hoekstra R; van der Hoeven TV; Ackermans MT; Hakvoort TB; van Gulik TM; Chamuleau RA
Liver Int; 2013 Apr; 33(4):516-24. PubMed ID: 23387413
[TBL] [Abstract][Full Text] [Related]
16. Scaling-up of a HepaRG progenitor cell based bioartificial liver: optimization for clinical application and transport.
van Wenum M; Treskes P; Tang CY; Coppens EJ; Jansen K; Hendriks EJ; Camus S; van Gulik TM; Chamuleau RAFM; Hoekstra R
Biofabrication; 2017 Jun; 9(3):035001. PubMed ID: 28664876
[TBL] [Abstract][Full Text] [Related]
17. Advances in cell sources of hepatocytes for bioartificial liver.
Pan XP; Li LJ
Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):594-605. PubMed ID: 23232630
[TBL] [Abstract][Full Text] [Related]
18. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes.
Soto-Gutiérrez A; Kobayashi N; Rivas-Carrillo JD; Navarro-Alvarez N; Zhao D; Okitsu T; Noguchi H; Basma H; Tabata Y; Chen Y; Tanaka K; Narushima M; Miki A; Ueda T; Jun HS; Yoon JW; Lebkowski J; Tanaka N; Fox IJ
Nat Biotechnol; 2006 Nov; 24(11):1412-9. PubMed ID: 17086173
[TBL] [Abstract][Full Text] [Related]
19. Bioartificial livers: a review of their design and manufacture.
Tuerxun K; He J; Ibrahim I; Yusupu Z; Yasheng A; Xu Q; Tang R; Aikebaier A; Wu Y; Tuerdi M; Nijiati M; Zou X; Xu T
Biofabrication; 2022 Jun; 14(3):. PubMed ID: 35545058
[TBL] [Abstract][Full Text] [Related]
20. In vivo estimation of bioartificial liver with recombinant HepG2 cells using pigs with ischemic liver failure.
Enosawa S; Miyashita T; Fujita Y; Suzuki S; Amemiya H; Omasa T; Hiramatsu S; Suga K; Matsumura T
Cell Transplant; 2001; 10(4-5):429-33. PubMed ID: 11549067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
